A detailed history of Financial Avengers, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Financial Avengers, Inc. holds 177 shares of ABBV stock, worth $31,718. This represents 0.02% of its overall portfolio holdings.

Number of Shares
177
Previous 177 -0.0%
Holding current value
$31,718
Previous $30,000 13.33%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $20,122 - $23,498
130 Added 276.6%
177 $30,000
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $159 - $182
1 Added 2.17%
47 $8,000
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $6,145 - $7,113
46 New
46 $6,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Financial Avengers, Inc. Portfolio

Follow Financial Avengers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Avengers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Avengers, Inc. with notifications on news.